Baker's yeast is one of biotechnology's most important microorganisms. It has long been used to leaven bread and ferment beer. More recently, advances in synthetic biology have enabled engineered yeast to convert sugar into a wide range of products, including medicines, fuels and industrial chemicals. Yet even well-engineered yeast cells can be difficult to control in a precise and timely way.

Baker's yeast is one of biotechnology's most important microorganisms. It has long been used to leaven bread and ferment beer. More recently, advances in synthetic biology have enabled engineered yeast to convert sugar into a wide range of products, including medicines, fuels and industrial chemicals. Yet even well-engineered yeast cells can be difficult to control in a precise and timely way.

Every living cell, from the simplest bacterium to a human neuron, relies on the same basic machinery to read, interpret, and use its DNA. This molecular machinery is so fundamental that life as we know it cannot exist without it. And because it is so essential, it has long been a target for drugs; it shuts down a bacterium's ability to access its own genes and it quickly dies.

Photosynthetic microorganisms can use light energy to convert carbon dioxide into useful compounds under mild, environmentally compatible conditions. However, many current photosynthetic production systems rely on cells growing freely in large volumes of liquid. This creates a substantial demand for water and requires extensive mixing to keep the cells evenly distributed and exposed to light, increasing the resource and energy requirements of the process.

For most healthy people, Cryptococcus is an unnoticed infection. The immune system walls it off in the lungs and keeps it dormant for life. But in patients undergoing cancer chemotherapy, recovering from an organ transplant, living with HIV or taking newer immunosuppressing drugs for autoimmune disease, the fungus can reactivate, spread to the brain and cause meningitis.

Researchers led by Sa Kan Yoo at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have discovered that the natural turnover of gut cells in fruit flies depends on how much food the flies get, rather than on any specific nutrient. They found that gut cells were replaced more frequently when nutrient levels were low and the insides of gut cells were fluid and watery.

Researchers led by Sa Kan Yoo at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have discovered that the natural turnover of gut cells in fruit flies depends on how much food the flies get, rather than on any specific nutrient. They found that gut cells were replaced more frequently when nutrient levels were low and the insides of gut cells were fluid and watery.

Malaria parasites proliferate in an unusual way. Rather than dividing into two daughter cells like human cells, they first amplify their genetic material tenfold, hundredfold or even thousandfold before simultaneously producing a corresponding number of daughter parasites. Until now, the mechanisms controlling these processes were only partly understood.

Xenophagocytosis is a natural immune process that limits interspecies organ generation by eliminating living donor cells, researchers at the Institute of Science Tokyo, Japan, report. By uncovering how embryonic macrophages eliminate living donor cells, the researchers developed strategies to block this response. Using this strategy, they significantly improved donor cell survival and the generation of rat pancreas in mice, bringing us one step closer to producing transplantable human organs in animals.

Every time a cell divides, it must accurately copy and distribute its DNA between two new cells. However, in some cases, chromosomes do not fully separate, leaving behind thin strands of DNA known as DNA bridges that connect the two newly formed cells.

La Trobe University scientists have uncovered the critical role fatty cell structures play in our body's early detection and defense against viruses. Published in Nature Communications, the discovery could open the door to a new type of antiviral strategy that harnesses the body's innate defense mechanisms rather than targeting individual viruses.

Cells are like metropolises, home to millions of molecular residents. If one were to stand atop a high-rise, trying to identify most of its inhabitants would seem an impossible task. Even with the sophisticated imaging tools currently available to scientists, it is challenging to zoom in on specific molecules and view them with a high degree of detail.

Another last-resort antibiotic has fallen victim to the rapid evolution of drug-resistant superbugs. The powerful antibiotic combination ceftazidime-avibactam (CZA), widely used to treat severe hospital-acquired infections caused by Pseudomonas aeruginosa—particularly in critically ill and immunocompromised patients—can no longer eliminate some of these infections.

Researchers at Queen Mary University of London have discovered that tiny photosynthetic bacteria band together into protective "herds" when attacked by predators—a survival strategy that could also influence how carbon is stored in the world's waters.

The nucleolus is a liquid-like cellular organelle where protein factories called ribosomes are assembled. Researchers knew of three distinct compartments within the nucleolus, but how these compartments function to drive ribosome assembly was unclear. A study from St. Jude Children's Research Hospital, published today in Molecular Cell, reveals that smaller subcompartments containing ribosome building blocks and assembly proteins spontaneously form to finish the final steps of ribosome assembly. This reveals unprecedented levels of organization behind the process and may offer insight into diseases associated with increased ribosome production, such as cancer.